Nitric oxide and hypertension: Not just an endothelium derived relaxing factor!

Journal of Human Hypertension

Volumn 15, Issue 4, 2001, Pages 219-227

  Chowdhary, S ^a   Townend, J N ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Autonomic nervous system; Hypertension; Nitric oxide

Indexed keywords

ARTERIAL PRESSURE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR FUNCTION; ENDOTHELIUM; ESSENTIAL HYPERTENSION; HOMEOSTASIS; HUMAN; HUMAN FACTORS RESEARCH; HYPERTENSION; INHIBITION KINETICS; NEUROMODULATION; NONHUMAN; PRESSORECEPTOR REFLEX; REVIEW; SYMPATHETIC FUNCTION; VAGUS TONE; VASODILATATION;

EID: 0035068439     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001165     Document Type: Review

References (100)

1. Twenty-year follow-up of hemodynamics in essential hypertension during rest and exercise
2. Hemodynamic predictors of incident hypertension. The Framingham Heart Study
3. "Structural factor" in primary and secondary hypertension
4. Plasma catecholamines and essential hypertension. An analytical review
5. Plasma norepinephrine and epinephrine levels in essential hypertension
6. Plasma catecholamines and adrenoceptors in young hypertensive patients
7. Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension
8. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings
9. Age-related changes in muscle sympathetic nerve activity in essential hypertension
10. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension
11. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension
12. Single-unit sympathetic discharge: Quantitative assessment in human hypertensive disease
13. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system
14. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population
15. Pathophysiology of obesity-related hypertension: Role of insulin and the sympathetic nervous system
16. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
17. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?
18. Control of regional blood flow by endothelium-derived nitric oxide
19. Systemic and regional hemodynamics after nitric oxide synthase inhibition: Role of a neurogenic mechanism
20. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin
21. Sympathetic modulation of endothelium-derived relaxing factor
22. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats
23. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans
24. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?
25. Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxide synthesis inhibition in humans
26. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of NG-monomethyl-L-arginine into humans are dose dependent
27. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans
28. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
29. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal
30. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension
31. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension
32. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
33. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients
34. Preserved endothelium-dependent vasodilation in patients with essential hypertension
35. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension
36. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension
37. The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension
38. Acute hypertension impairs endothelium-dependent vasodilation
39. Basal nitric oxide synthesis in essential hypertension
40. Role of nitric oxide in the regulation of cardiovascular autonomic control
41. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide
42. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo
43. Chronic nitric oxide inhibition with L-NAME: Effects on autonomic control of the cardiovascular system
44. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?
45. Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats
46. Inhibition of NO synthesis minimally affects the dynamic baroreflex regulation of sympathetic nerve activity
47. Role of nitric oxide in regulation of baroreceptor reflex
48. Central inhibition of nitric oxide synthesis increases blood pressure and heart rate in anesthetized rats
49. Central nitric oxide attenuates the baroreceptor reflex in conscious rabbits
50. A central nervous system action of nitric oxide in blood pressure regulation
51. Role of endogenous nitric oxide in the brain stem on the rapid adaptation of baroreflex
52. Cardiovascular regulation by L-arginine in the brain of rats: Role of the brain renin-angiotensin system and nitric oxide
53. Inhibition of nitric oxide formation in the nucleus tractus solitarious increases renal sympathetic nerve activity in rabbits
54. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats
55. Effects of L-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarius
56. Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brain-stem slices
57. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide
58. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat
59. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity
60. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: Role of GABA
61. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits
62. Blockade of neuronal nitric oxide synthase alters the baroreflex control of heart rate in the rabbit
63. The effects of intrinsic nitric oxide on cardiac neural regulation in cats
64. Stress-induced activation of nitric oxide-producing neurons in the rat brain
65. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
66. Effect of sodium nitroprusside and 8-bromo-cyclic GMP on the sympathetic control of heart rate and contraction in the isolated guinea-pig atria
67. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility
68. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation
69. Effect of neuronal nitric oxide synthase inhibition on the heart rate response to cardiac sympathetic and vagal nerve stimulation in the anaesthetized rabbit
70. Nitric oxide synthase inhibits the cardioaccelerator rate response to sympathetic stimulation in the anaesthetized ferret
71. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves
72. Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: Nitric oxide modulates sympathetic effects on ventricular electrophysiological properties
73. Nitric oxide synthase in cardiac sarcoplasmic reticulum
74. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
75. Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors
76. Guanylate-cyclase-mediated inhibition of cardiac ICa by carbachol and sodium nitroprusside. Pflugers Archiv
77. Nitric oxide enhances the inotropic response to beta-adrenergic stimulation in the isolated guinea-pig heart
78. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes
79. Myocardial contractile response to nitric oxide and cGMP
80. Regulation of cardiac beta-adrenergic response by nitric oxide
81. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery
82. Endothelium inhibits responses of rabbit carotid artery to adrenergic nerve stimulation
83. Release of norepinephrine from adrenergic nerve endings of blood vessels is modulated by endothelium-derived relaxing factor
84. Inhibition of sympathetic neurotransmitter release by modulators of cyclic GMP in canine vascular smooth muscle
85. Nitric oxide-mediated excitatory effect on neurons of dorsal motor nucleus of vagus
86. Modulation of vagal actions on heart rate produced by inhibition of nitric oxide synthase in the anaesthetized ferret
87. The role of nitric oxide in the control by the vagal nerves of the heart of the ferret
88. Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart
89. NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation
90. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes
91. Role of nitric oxide in the rate and contraction responses to acetylcholine following adrenergic stimulation in the isolated frog heart
92. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs
93. Nitric oxide and cardiac autonomic control in humans
94. Role of endogenous nitric oxide in the nucleus tratus solitarii on baroreflex control of heart rate in spontaneously hypertensive rats
95. Central depressor action of nitric oxide is deficient in genetic hypertension
96. Gene expression of brain nitric oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats
97. Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension
98. Lower than normal expression of brain nitric oxide synthase gene in the hypothalamus of deoxycorticosterone acetate-salt hypertensive rats
99. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney
100. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice